Neuroimaging to predict preclinical Alzheimer's disease

被引：2
|
作者：
Kumari, V
Mitterschiffthaler, MT
Sharma, T
机构：
[1] Inst Psychiat, Div Psychol Med, Sect Cognit Psychopharmacol, London SE5 8AF, England
[2] Inst Psychiat, Dept Psychol, London SE5 8AF, England
[3] Stonehouse Hosp, Res Ctr, Dartford, Kent, England
来源：
HOSPITAL MEDICINE | 2002年 / 63卷 / 06期
关键词：
D O I：
10.12968/hosp.2002.63.6.2004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Alzheimer's disease is common in the elderly and causes tremendous distress to patients and their carers. With the advent of newer pharmacological treatments, significant improvement in the early diagnosis of Alzheimer's disease is required. This article examines the usefulness of neuroimaging techniques to predict Alzheimer's disease in prediagnosis individuals.
引用
收藏
页码：341 / 345
页数：5
相关论文
共 50 条
  • [31] Alzheimer's disease neuroimaging initiative
    Mueller, Susanne G.
    Weiner, Michael W.
    Thal, Leon J.
    Petersen, Ronald C.
    Jack, Clifford
    Jagust, William
    Trojanowski, John Q.
    Toga, Arthur W.
    Beckett, Laurel
    ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES, 2008, 57 : 183 - 189
  • [32] Neuroimaging and early Alzheimer's disease
    Smith, AD
    Jobst, KA
    Edmonds, Z
    Hindley, NJ
    King, EMF
    LANCET, 1996, 348 (9030): : 829 - 830
  • [33] Advances on Alzheimer's Disease With Neuroimaging
    He Yong
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2012, 39 (08) : 811 - 815
  • [34] Neuroimaging of delusions in Alzheimer's disease
    Ismail, Zahinoor
    Minh-Quan Nguyen
    Fischer, Corinne E.
    Schweizer, Tom A.
    Mulsant, Benoit H.
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2012, 202 (02) : 89 - 95
  • [35] Neuroimaging biomarkers in Alzheimer's disease
    Nestor, Peter
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [36] Neuroimaging Biomarkers for Alzheimer’s Disease
    Freddie Márquez
    Michael A. Yassa
    Molecular Neurodegeneration, 14
  • [37] Molecular Neuroimaging in Alzheimer's Disease
    Jagust W.
    NeuroRX, 2004, 1 (2): : 206 - 212
  • [38] Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease
    Ng, Kok Pin
    Pascoal, Tharick A.
    Mathotaarachchi, Sulantha
    Chung, Chang-Oh
    Benedet, Andrea L.
    Shin, Monica
    Kang, Min Su
    Li, Xiaofeng
    Ba, Maowen
    Kandiah, Nagaendran
    Rosa-Neto, Pedro
    Gauthier, Serge
    NEUROLOGY, 2017, 88 (19) : 1814 - 1821
  • [39] Alzheimer's disease neurodegeneration markers in Alzheimer's disease neuroimaging initiative
    Andriuta, D.
    Moullart, V.
    Schraen, S.
    Meyer, M. -E.
    Godefroy, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 93 - 93
  • [40] Utility of Recognition Discriminability Index to Predict Conversion From Mild Cognitive Impairment to Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative
    Russo, Maria Julieta
    Campos, Jorge
    Cohen, Gabriela
    Sevlever, Gustavo
    Allegri, Ricardo
    NEUROLOGY, 2017, 88
12345